[(3S,9S,10R,13R,14R,17R)-17-[(2S,3R,4R,5S)-3,4-diacetyloxy-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate

C35H54O6 — CID 10721779

IUPAC[(3S,9S,10R,13R,14R,17R)-17-[(2S,3R,4R,5S)-3,4-diacetyloxy-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
SMILESCC[C@@H](C(C)C)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](OC(C)=O)CC[C@]4(C)[C@H]3CC[C@]12C
InChIInChI=1S/C35H54O6/c1-10-27(20(2)3)33(41-24(7)38)32(40-23(6)37)21(4)29-13-14-30-28-12-11-25-19-26(39-22(5)36)15-17-34(25,8)31(28)16-18-35(29,30)9/h11-12,20-21,26-27,29-33H,10,13-19H2,1-9H3/t21-,26-,27-,29+,30-,31-,32+,33+,34-,35+/m0/s1
InChIKeyIUILDXMGAWUWKJ-FOVYFZJRSA-N
MW570.81 g/mol
LogP7.60
Rot. Bonds9

About [(3S,9S,10R,13R,14R,17R)-17-[(2S,3R,4R,5S)-3,4-diacetyloxy-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate

[(3S,9S,10R,13R,14R,17R)-17-[(2S,3R,4R,5S)-3,4-diacetyloxy-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate (PubChem CID 10721779) has the molecular formula C35H54O6 and a molecular weight of 570.81 g/mol. Its IUPAC name is [(3S,9S,10R,13R,14R,17R)-17-[(2S,3R,4R,5S)-3,4-diacetyloxy-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate.

Molecular Properties

Compound Name[(3S,9S,10R,13R,14R,17R)-17-[(2S,3R,4R,5S)-3,4-diacetyloxy-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
PubChem CID10721779
Molecular FormulaC35H54O6
Molecular Weight570.81 g/mol
Exact Mass570.39
IUPAC Name[(3S,9S,10R,13R,14R,17R)-17-[(2S,3R,4R,5S)-3,4-diacetyloxy-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
SMILESCC[C@@H](C(C)C)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](OC(C)=O)CC[C@]4(C)[C@H]3CC[C@]12C
InChIInChI=1S/C35H54O6/c1-10-27(20(2)3)33(41-24(7)38)32(40-23(6)37)21(4)29-13-14-30-28-12-11-25-19-26(39-22(5)36)15-17-34(25,8)31(28)16-18-35(29,30)9/h11-12,20-21,26-27,29-33H,10,13-19H2,1-9H3/t21-,26-,27-,29+,30-,31-,32+,33+,34-,35+/m0/s1
InChIKeyIUILDXMGAWUWKJ-FOVYFZJRSA-N
XLogP7.60
TPSA78.90 Ų
H-Bond Donors
H-Bond Acceptors6
Rotatable Bonds9
Heavy Atoms41
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500570.81
LogP ≤ 57.60
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}

Analyze [(3S,9S,10R,13R,14R,17R)-17-[(2S,3R,4R,5S)-3,4-diacetyloxy-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

[(3S,9S,10R,13S,14R,17S)-17-[(1R)-1-hydroxyethyl]-10,13-dimethyl-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
CID 10970391
[(3R,9S,10R,13S,14S,17S)-17-[(2S,5R)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
CID 125031969
[(3R,9S,10S,13S,14S,17R)-17-[(2R,5S)-5,6-dimethylheptan-2-yl]-10,13-dimethyl-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
CID 125031410
[(3S,9S,10R,13R,14R,17R)-17-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
CID 6436903
[(3S,9S,10R,13R,14R,17R)-17-[(2R,5S)-5-acetyloxy-6-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
CID 22797806
[(3S,9R,10R,13R,14S,17R)-10,13-dimethyl-17-[(E,2R)-6-methylhept-3-en-2-yl]-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
CID 163029556
[(3S,9S,10R,13R,14R,17R)-10,13-dimethyl-17-[(E,2R)-6-methyl-5-methylidenehept-3-en-2-yl]-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
CID 57339329
[(3S,9S,10R,13R,14R,17R)-17-[(E,2R)-5,6-dihydroxy-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
CID 131668092
[(3S,9S,10R,13R,14R,17R)-17-[(2R,5S)-5,6-dimethylheptan-2-yl]-10,13-dimethyl-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] benzoate
CID 54405366
[(3S,9S,10R,13R,14R,17R)-17-[(2S)-butan-2-yl]-10,13-dimethyl-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy-tri(propan-2-yl)silane
CID 59761007
[(Z)-2-[3-(methoxymethoxy)-10,13-dimethyl-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]hex-4-en-3-yl] propanoate
CID 5379789
[(3S,9S,10R,13R,14R,17R)-10,13-dimethyl-17-[(2R)-6-methylhepta-3,5-dien-2-yl]-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] benzoate
CID 163069188

Frequently Asked Questions

What is the IUPAC name of [(3S,9S,10R,13R,14R,17R)-17-[(2S,3R,4R,5S)-3,4-diacetyloxy-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate?
The IUPAC name of [(3S,9S,10R,13R,14R,17R)-17-[(2S,3R,4R,5S)-3,4-diacetyloxy-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate (CID 10721779) is [(3S,9S,10R,13R,14R,17R)-17-[(2S,3R,4R,5S)-3,4-diacetyloxy-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate.
What is the SMILES notation for [(3S,9S,10R,13R,14R,17R)-17-[(2S,3R,4R,5S)-3,4-diacetyloxy-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate?
The canonical SMILES for [(3S,9S,10R,13R,14R,17R)-17-[(2S,3R,4R,5S)-3,4-diacetyloxy-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate is CC[C@@H](C(C)C)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](OC(C)=O)CC[C@]4(C)[C@H]3CC[C@]12C.
What is the InChIKey of [(3S,9S,10R,13R,14R,17R)-17-[(2S,3R,4R,5S)-3,4-diacetyloxy-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate?
The InChIKey is IUILDXMGAWUWKJ-FOVYFZJRSA-N. The full InChI is InChI=1S/C35H54O6/c1-10-27(20(2)3)33(41-24(7)38)32(40-23(6)37)21(4)29-13-14-30-28-12-11-25-19-26(39-22(5)36)15-17-34(25,8)31(28)16-18-35(29,30)9/h11-12,20-21,26-27,29-33H,10,13-19H2,1-9H3/t21-,26-,27-,29+,30-,31-,32+,33+,34-,35+/m0/s1.
What are the key properties of [(3S,9S,10R,13R,14R,17R)-17-[(2S,3R,4R,5S)-3,4-diacetyloxy-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate?
[(3S,9S,10R,13R,14R,17R)-17-[(2S,3R,4R,5S)-3,4-diacetyloxy-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate has a molecular weight of 570.81 g/mol, XLogP of 7.60, 9 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for [(3S,9S,10R,13R,14R,17R)-17-[(2S,3R,4R,5S)-3,4-diacetyloxy-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate is sourced from PubChem (CID 10721779), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).